SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · United Therapeutics CEO Martine Rothblatt sold 1,156 shares in two…

UNITED THERAPEUTICS Corp · CLUSTER filed Mar 5, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Mar 5, 2026 at 19:00 ET

United Therapeutics CEO Martine Rothblatt sold 1,156 shares in two open-market transactions totaling $616,635 over the past week, while also exercising options for 19,000 shares at a mix of $0 and $146.03 strike prices. The sales represent a small fraction of market cap and are likely part of pre-arranged trading plans or tax-related activity following option exercises.

  • CEO Martine Rothblatt sold 1,156 shares in open-market transactions for $616,635 over two days.
  • Concurrent with the sales, Rothblatt exercised 19,000 derivative securities, including 9,500 shares at $0 (likely RSU vesting) and 9,500 at $146.03 (in-the-money options).
  • Total open-market sale value: $616,635, approximately 0.0026% of $23.5B market cap.
  • All transactions occurred within a 5-day window, suggesting coordinated activity likely tied to option exercise and tax obligations.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access